Russell Hausfeld / TruthdigMar 21, 2024
Rick Doblin, the pioneer of MDMA therapy, advocates for dosing soldiers upon enlistment. Dig deeper ( 4 Min. Read )
Russell Hausfeld / TruthdigJan 11, 2024
The pioneering psychedelics advocacy group has traded its “public benefit model” for one closer to traditional pharma. Dig deeper ( 3 Min. Read )
Russell Hausfeld / TruthdigNov 30, 2022
In previously unreported statements made at the 2017 International Drug Policy Reform Conference, Rick Doblin, executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), discussed rumors of secret Pentagon studies with MDMA, as well as the reasons for hesitancy on the part of some government agencies to fund MAPS’ research. Dig deeper ( 2 Min. Read )
Join our newsletterStay up to date with the latest from Truthdig. Join the Truthdig Newsletter for our latest publications.
Now you can personalize your Truthdig experience. To bookmark your favorite articles and follow your favorite authors, please login or create a user profile.
Now you can personalize your Truthdig experience. To bookmark your favorite articles and follow your favorite authors, upgrade to supporter.